Publications
- SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors2021 | Second Faculty of Medicine
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma2013 | Second Faculty of Medicine
- FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer2009 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
- Content and specificity of the Anti-SARS-CoV-2 antibodies in solutions for immunoglobulin replacement therapy2023 | Second Faculty of Medicine
- Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients2022 | Second Faculty of Medicine, First Faculty of Medicine
- Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein-specific T cells in Lung Transplant Recipients2022 | Second Faculty of Medicine, First Faculty of Medicine
- Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy2022 | Second Faculty of Medicine
- Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients2021 | Second Faculty of Medicine, First Faculty of Medicine
Loading network view...